Antheia Secures $80 Million Conditional Funding Commitment from Department of War's Office of Strategic Capital
Financing supports Antheia's domestic manufacturing strategy to onshore critical medicine supply chains MENLO PARK, Calif., Oct. 18, 2026 /PRNewswire/ -- Antheia, the advanced biosynthesis company delivering 21st-century pharmaceutical manufacturing and innovation, today announced it has...
Covered in this story
Call it yourself
No calls on $PARK yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Park Dental Partners →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.